Ligand blot analysis of insulin-like growth factor-binding proteins using biotinylated insulin-like growth factor-I

Hormone Research

Volumn 49, Issue 1, 1998, Pages 1-7

  Grulich Henn, J ^a,b   Spiess, S ^a   Heinrich, U ^a   Schonberg D ^a   Bettendorf, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Binding proteins, IGF; Biotinylation; Chemiluminescence; Insulin like growth factor; Ligand blot

Indexed keywords

PEROXIDASE; PYROXYLIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; STREPTAVIDIN;

ARTICLE; BIOTINYLATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; HUMAN; IMMUNOBLOTTING; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ADULT; BIOTINYLATION; BLOTTING, WESTERN; CHILD; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; SENSITIVITY AND SPECIFICITY; SODIUM DODECYL SULFATE; SOMATOMEDINS;

EID: 0031984022     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023118     Document Type: Article

References (39)

1. LeRoith D, Adamo M, Werner H, Roberts CT: Molecular and cellular biology of the insulin-like growth factors; in Weintraub BD (ed): Molecular Endocrinology: Basic Concepts and Clinical Correlations. New York, Raven Press, 1995, pp 181-193.
2. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995;16:3-34.
3. Shimasaki S, Ling N: Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 1991;3:243-266.
4. Matsumoto T, Gargosky SE, Iwasaki K, Rosenfeld RG: Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metab 1996;81:150-155.
5. Drop SLS, Schuller AGP, Lindenbergh-Kortleve DJ, Groffen C, Brinkman A, Zwarthoff EC: Structural aspects of the IGFBP family. Growth Regul 1992;2:69-79.
6. Mohan S, Baylink DJ, Pettis JL: Editorial: Insulin-like growth factor (IGF)-binding proteins in serum: Do they have additional roles besides modulating the endocrine IGF actions? J Clin Endocrinol Metab 1996;81:3817-3820.
7. Jones JI, Busby WH, Wright G, Smith CE, Kimack NM, Clemmons DR: Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1: Regulation of its affinity by phosphorylation of serine 101. J Biol Chem 1993;269:1125-1131.
8. Hoeck WG, Mukko VR: Identification of the major sites of phosphorylation in IGF binding protein-3. J Cell Biochem 1994;56:262-273.
9. Clemmons DR, Busby WH, Arai T, Nam TJ, Clarke JB, Jones JI, Ankrapp DK: Role of insulin-like growth factor binding proteins in the control of IGF actions. Prog Growth Factor Res 1995;6:357-366.
10. Fowlkes JL, Freekmark M: Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulation IGF-binding protein-4 in dermal fibroblasts. Endocrinology 1992;131: 2071-2076.
11. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H: Matrix metallproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 1994;269: 25742-25746.
12. Lee GY, Rechler MM: Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cationdependent protease activity in adult rat serum promotes the release of bound IGF-I. Endocrinology 1996;137:2051-2058.
13. Besnard N, Pisselet C, Zapf J, Hornbeck W, Monniaux D, Monget P: Proteolytic activity is involved in changes in intrafollicular insulin-like growth factor-binding protein levels during growth and atresia of ovine ovarian follicles. Endocrinology 1996;137:1599-1607.
14. Blat C, Villaudy J, Binoux M: In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest 1994;93: 2286-2290.
15. Campell PG, Novak JF, Yanosick TB, McMaster JH: Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex. Endocrinology 1992; 130:1401-1412.
16. Ernst CW, White ME: Hormonal regulation of IGF-binding protein-2 expression in proliferating C2C12 myoblasts. J Endocrinol 1996;149: 417-429.
17. Giannini S, Maggi M, Cresci B, Finetti G, Bonaccorsi L, Luconi M, Rotella CM, Forti G, Serio M, Baldi E: Platelet-activating factor enhances production of insulin-like growth factor binding proteins in a human adenocarcinoma cell line (HEC-1A). Gynecol Oncol 1996;61: 333-340.
18. Babajko S, Binoux M: Modulation by retionic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells. Eur J Endocrinol 1996;134:474-480.
19. Duan C, Hawes SB, Prevette T, Clemmons DR: Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J Biol Chem 1996;271: 4280-4288.
20. Frystyk J, Vinter Jensen L, Skjaerbaek C, Flyvbjerg A: The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats. Growth Regul 1996;6:48-54.
21. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M: Analysis of serum IGFBPs using Western-Blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986;154:138-143.
22. Blum W, Beier BH: Radioimmunoassays for IGFs and IGFBPs. Growth Regul 1994;4(suppl 1):11-19.
23. Koistinen R, Stenman UH, Alfthan H, Seppälä M: Time-resolved immunofluorometric assay of 34 kDa somatomedin-binding protein. Clin Chem 1987;33:1126-1128.
24. Grulich-Henn J, Preissner KT, Müller-Berghaus G: Heparin stimulates fibrinolysis in mesothelial cells by selective induction of tissue-plasminogen activator but not plasminogen activator inhibitor-1 synthesis. Thromb Haemost 1990;64:420-425.
25. Fazleabas AT, Donnelly KM: Characterization of insulin-like growth factor binding proteins by two-dimensional polyacrylamide gel electrophoresis and ligand blot analysis. Anal Biochem 1992;202:40-45.
26. Ranke M, Blum WF, Bierich JR: Clinical relevance of serum measurement of insulin-like growth factors and somatomedin binding proteins. Acta Paediatr Scand 1988;347:114-126.
27. Davenport ML, Isley WL, Pucilowska JB, Pemberton LB, Lyman B, Underwood LE, Clemmons DR: Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab 1992;75:590-595.
28. Cataldo NA, Giudice LC: Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status. J Clin Endocrinol Metab 1992;74: 821-829.
29. Cataldo NA, Giudice LC: Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome. J Clin Endocrinol Metab 1992;74:695-697.
30. Price WA, Rong L, Stiles AD, D'Ercole AJ: Changes in IGF-I and -II, IGF binding protein, and IGF receptor transcript abundance after uterine artery ligation. Pediatr Res 1992;32: 291-295.
31. Coulson VJ, Wass JA, Abdulla AF, Cotterill AM, Holly JM: Insulin-like growth factor binding proteins (IGFBPs) in acromegaly. Growth Regul 1991;1:119-124.
32. Müller HL, Oh Y, Lehrnbecher T, Blum WF, Rosenfeld RG: Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab 1994;79:428-434.
33. Tönshoff B, Blum WF, Mehls O: Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease. Pediatr Nephrol 1996;10:269-274.
34. Bereket A, Lang CH, Blethen SL, Wilson TA: Insulin-like growth factor-binding protein-2 and insulin: studies in children with type 1 diabetes mellitus and maturity-onset diabetes of the young. J Clin Endocrinol Metab 1995;80: 3647-3652.
35. Knip M, Tapanainen P, Pekonen F, Blum WF: Insulin-like growth factor binding proteins in prepubertal children with insulin-dependent diabetes mellitus. Eur J Endocrinol 1995;133: 440-444.
36. Blum WF, Ranke MB, Kietzmann K, Tönshoff B, Mehls O: Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uremia. Pediatr Nephrol 1991;5:539-544.
37. Kratzsch J, Blum WF, Schenker E, Keller E: Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins-1, -2, -3 and GH binding protein during progression of liver cirrhosis. Exp Clin Endocrinol Diabetes 1995;103:285-291.
38. Holt RI, Jones JS, Stone NM, Baker AJ, Miell JP: Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation. J Clin Endocrinol Metab 1996;81:160-168.
39. Cotterill AM, Mendel P, Holly JM, Timmins AG, Camacho Hubner C, Hughes SC, Ross RM, Blum WF, Langford RM: The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery. Clin Endocrinol (Oxf) 1996;44:91-101.